 |
|
U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat
November 09, 2009Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. During a summit held this week in Washington, D.C., President Obama and Prime Minister Reinfeldt joined forces to address the urgency of the problem and the need for solutions by signing an international agreement that seeks cooperative ways in which the United States and EU countries can help combat the global health crisis.
The World Health Organization (WHO) has identified antimicrobial resistance as one of the three greatest threats to human health. Antimicrobial drugs are used around the world to fight viral diseases, like 2009 H1N1 influenza; bacterial infections, like Staphylococcus aureus and tuberculosis; parasitic infections, like malaria; and fungal infections. Many of these pathogens are becoming increasingly resistant to antimicrobials.
"Antimicrobial resistance and the lack of new antimicrobial agents to effectively treat resistant infections are problems that no country can deal with alone-they threaten the very foundation of medical care," said Richard Whitley, MD, FIDSA, president of the Infectious Diseases Society of America (IDSA). "Without effective antimicrobial drugs, modern medical treatments such as operations, transplants, intensive care, cancer treatment and care of premature babies will become very risky if not impossible." Dr. Whitley joined with Javier Garau, MD, president of European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Shelley A. Hearne, managing director of the Pew Health Group in welcoming the multi-country initiative.
"We are thrilled to see the United States and European Union take this important first step to control the spread of serious and life-threatening antimicrobial resistant organisms and to advance the development of much-needed antimicrobial drugs," said Dr. Garau. "Clinicians, scientists, public health experts, veterinarians, economists and health policy experts all have critical roles to play in ensuring the success of this cooperative effort, which will benefit people around the world.
The task force will begin its work by identifying and agreeing on important issues related to antimicrobial resistance, in areas including the appropriate use of antimicrobial drugs in medical and veterinary communities, prevention of both health care- and community-associated drug-resistant infections, and strategies for improving the antimicrobial drug pipeline. The task force also will produce concrete action plans that build on international cooperation and provide regular reports on the initiative's progress.
"Antibiotic resistant bacteria respect no political borders, so we must work together to combat them," Dr. Hearne said. "Resistance takes a terrible toll on health worldwide and is measured in lives lost, greater suffering and higher health care costs. One way that U.S. leaders can demonstrate their commitment to solving this issue is by immediately joining the EU in banning non-judicious antibiotic uses in food animal production."
Drug-resistant infections kill tens of thousands of people in the United States each year. Methicillin-resistant Staphylococcus aureus (MRSA) alone infects more than 94,000 people and kills nearly 19,000 Americans every year, more deaths than caused by emphysema, HIV/AIDS, Parkinson's disease, and homicide. A new interactive map on IDSA's website describes in detail the local impact of these and other resistant infections across the nation with detailed U.S. state-specific information.
Two recent European reports, similar to IDSA's 2004 "Bad Bugs, No Drugs" report, describe the growing problem of antibiotic resistance in Europe and highlight possible strategies to stimulate the development of new drugs. Approximately 25,000 people die each year in Europe from just five resistant infections analyzed in one report, drafted by the European Center for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMEA). The other major report, from the London School of Economics and Political Science, outlines possible policy options and incentives to kick start research and development into new antimicrobial drugs and diagnostics. Both reports are available at: www.se2009.eu/en/meetings_news/2009/9/17/conference_innovative_incentives_for_effective_antibacterials
"The next step forward must be to bring together an interdisciplinary group of experts from the scientific, medical, public health and economic communities to establish international priorities and develop a joint plan for action," Dr. Whitley said. "By exchanging best practices and sharing experiences from both continents, together we can begin developing a global solution to address this dangerous worldwide threat."
The Infectious Diseases Society of America (IDSA)
"We are thrilled to see the United States and European Union take this important first step to control the spread of serious and life-threatening antimicrobial resistant organisms and to advance the development of much-needed antimicrobial drugs," said Dr. Garau. "Clinicians, scientists, public health experts, veterinarians, economists and health policy experts all have critical roles to play in ensuring the success of this cooperative effort, which will benefit people around the world.
The task force will begin its work by identifying and agreeing on important issues related to antimicrobial resistance, in areas including the appropriate use of antimicrobial drugs in medical and veterinary communities, prevention of both health care- and community-associated drug-resistant infections, and strategies for improving the antimicrobial drug pipeline. The task force also will produce concrete action plans that build on international cooperation and provide regular reports on the initiative's progress.
"Antibiotic resistant bacteria respect no political borders, so we must work together to combat them," Dr. Hearne said. "Resistance takes a terrible toll on health worldwide and is measured in lives lost, greater suffering and higher health care costs. One way that U.S. leaders can demonstrate their commitment to solving this issue is by immediately joining the EU in banning non-judicious antibiotic uses in food animal production."
Drug-resistant infections kill tens of thousands of people in the United States each year. Methicillin-resistant Staphylococcus aureus (MRSA) alone infects more than 94,000 people and kills nearly 19,000 Americans every year, more deaths than caused by emphysema, HIV/AIDS, Parkinson's disease, and homicide. A new interactive map on IDSA's website describes in detail the local impact of these and other resistant infections across the nation with detailed U.S. state-specific information.
Two recent European reports, similar to IDSA's 2004 "Bad Bugs, No Drugs" report, describe the growing problem of antibiotic resistance in Europe and highlight possible strategies to stimulate the development of new drugs. Approximately 25,000 people die each year in Europe from just five resistant infections analyzed in one report, drafted by the European Center for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMEA). The other major report, from the London School of Economics and Political Science, outlines possible policy options and incentives to kick start research and development into new antimicrobial drugs and diagnostics. Both reports are available at: www.se2009.eu/en/meetings_news/2009/9/17/conference_innovative_incentives_for_effective_antibacterials
"The next step forward must be to bring together an interdisciplinary group of experts from the scientific, medical, public health and economic communities to establish international priorities and develop a joint plan for action," Dr. Whitley said. "By exchanging best practices and sharing experiences from both continents, together we can begin developing a global solution to address this dangerous worldwide threat."
The Infectious Diseases Society of America (IDSA)
Antibiotic Resistance Current Events and Antibiotic Resistance News RSSStudy reveals why certain drug combinations backfire
Combination drug therapy has become a staple for treating many infections. For instance, doctors treat extensively drug resistant forms of tuberculosis with one drug that breaks down the pathogen's protective barriers and opens the door for another to deliver the deathblow.
Bacteria 'launch a shield' to resist attack
Researchers from the University of Copenhagen and the Technical University of Denmark along with other collaborators in Denmark and the US found that the bacterium Pseudomonas aeruginosa can 'switch on' production of molecules that kill white blood cells - preventing the bacteria being eliminated by the body's immune system.
Misuse of antibiotics not the only cause of resistance says report
The perception that antibiotic resistance is primarily the undesirable consequence of antibiotic abuse or misuse is a view that is simplistic and inaccurate.
McMaster researchers discover a new antibacterial lead
Antibiotic resistance has been a significant problem for hospitals and health-care facilities for more than a decade. But despite the need for new treatment options, there have been only two new classes of antibiotics developed in the last 40 years.
Man-made crises 'outrunning our ability to deal with them,' scientists warn
The world faces a compounding series of crises driven by human activity, which existing governments and institutions are increasingly powerless to cope with, a group of eminent environmental scientists and economists has warned.
Genes key to staph disease severity, drug resistance found hitchhiking together
Scientists studying Staphylococcus bacteria, including methicillin-resistant S. aureus (MRSA), have discovered a potent staph toxin responsible for disease severity.
Resistance to antibiotics: When 1+1 is not 2
The evolution of multiple antibiotic resistances is a global and difficult problem to eradicate.
Ultrasensitive detector promises improved treatment of viral respiratory infections
A Vanderbilt chemist and a biomedical engineer have teamed up to develop a respiratory virus detector that is sensitive enough to detect an infection at an early stage, takes only a few minutes to return a result and is simple enough to be performed in a pediatrician's office.
Antibiotic prescribing should be standardized across Europe to help tackle resistance
Antibiotic prescribing for respiratory illnesses should be standardised across Europe to help reduce inappropriate prescribing and resistance.
Plant Microbe Shares Features with Drug-Resistant Pathogen
An international team of scientists has discovered extensive similarities between a strain of bacteria commonly associated with plants and one increasingly linked to opportunistic infections in hospital patients.
More Antibiotic Resistance Current Events and Antibiotic Resistance News Articles
 |
Revenge Of The Microbes: How Bacterial Resistance Is Undermining The Antibiotic Miracle by Abigail A. Salyers (Author), Dixie D. Whitt (Author) 'What is antibiotic resistance, and why should I be concerned with it?' Media coverage and political and scientific discussions about 'superbugs' that defy our current treatments, genetically-modified foods in our fields and grocery stores, the threat of bioterrorism, and the use of antibiotics in agriculture have increased citizen awareness and fears regarding the issues surrounding antibiotic resistance. "Revenge of the Microbes: How Bacterial Resistance Is Undermining the Antibiotic Miracle" is a single source of answers to this and other questions average people are asking. Written by experts with extensive experience in the field, "Revenge of the Microbes" provides the scientific information readers will need to form opinions and make informed decisions regarding the use of... |
 |
The Antibiotic Paradox: How the Misuse of Antibiotics Destroys Their Curative Powers by Stuart B Levy (Author), M.D., Stuart B. Levy (Author) Revised and updated with a new introduction by the author, the classic book that warns consumers about the overuse of antibiotics. In this totally revised and updated edition of the classic primer on the misuse of antibiotics, Dr. Stuart Levy reveals how our cavalier and naïve attitude about the power of antibiotics can have -and already has had-dire consequences. He explains that we are currently witnessing a massive evolutionary change in bacteria. This build-up of new antibiotic-resistant bacteria in individuals and the environment, mixed with our overzealous use of antibiotic soaps and the unregulated dispensing of antibiotics worldwide, is leading us into a dangerous territory where our "miracle" drugs will no longer help. |
 |
Antibiotic Resistance: Stopping the Superbugs Antibiotics was once seen as super drugs. They rapidly disarmed pneumonia and many other previously fatal bacterial conditions, and had relatively few side effects. But the bacteria weren't ready to surrender yet. Strains emerged that were resistant to the world's most potent medicines and now we're facing a world-wide crisis. In this program we see how the problem developed and what the experts believe we need to do to win the battle. This program is part of the award winning public television series Healthy Body, Healthy Mind. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Antibiotics: Actions, Origins, Resistance by Christopher Walsh (Author) Harvard Medical School, Boston, MA. Text analyzes how small molecules interfere selectively with the processes central to the survival of bacterial cells. Focuses on the relatively few molecules in antibiotics having an impact on human infectious disease. DNLM: Antibiotics--pharmacology. |
 |
Antibiotic Resistance: Stopping the Superbugs Directed By: ITV Also With: ITV (Producer) |
 |
Extending the Cure: Policy Responses to the Growing Threat of Antibiotic Resistance (Rff Press) by Professor Ramanan Laxminarayan (Author), Professor Anup Malani (Author), Professor David Howard (Author), Professor David L. Smith (Author) Our ability to treat common bacterial infections with antibiotics goes back only 65 years. However, the authors of this report make it clear that sustaining a supply of effective and affordable antibiotics cannot be without changes to the incentives facing patients, physicians, hospitals, insurers, and pharmaceutical manufacturers. In fact, increasing resistance to these drugs is already exacting a terrible price. Every day in the United States, approximately 172 men, women, and children die from infections caused by antibiotic-resistant bacteria in hospitals alone. Beyond those deaths, antibiotic resistance is costing billions of dollars through prolonged hospital stays and the need for doctors to resort to ever more costly drugs to use as substitute treatments. Extending the... |
 |
Enzyme-Mediated Resistance to Antibiotics: Mechanisms, Dissemination, and Prospects for Inhibition by Robert A. Bonomo (Editor), Marcelo E. Tolmasky (Editor) This book presents a state-of-the-art review of the mechanisms of resistance. The enzymes and enzyme systems detailed in this work include those involved in genetic reorganization, antibiotic modification and activation, antibiotic target modification, and antibiotic transport. |
|
Resistance vs. Tolerance: Persistence as a Mechanism of Antibiotic Resistance CD-ROM Starring: Kim Lewis Directed By: Ryan Jordan | |
 |
Antibiotic Policies: Fighting Resistance by Ian M. Gould (Author), Ian M. Gould (Editor), Jos W.M. van der Meer (Editor) Antibiotic resistance has reached epidemic proportions in most hospitals and many communities around the world. While control methods have traditionally (and usually unsuccessfully) relied on preventing cross infection it is increasingly obvious that new solutions are needed. There is growing evidence that the solution will lie in more careful use of antibiotics in the future. The golden age of antibiotic therapy has gone, probably for good and prescribers (and society at large) will have to accept that, in future, antibiotics will not be the "cure all" we have been accustomed to. This book addresses many of the key issues taxing our society and hospitals in an era of epidemic resistance and shortage of new antibiotics. Written by internationally renowned experts in the field, this... |
 |
Current Trends in Antibiotic Resistance in Infectious Diseases by Asad U. Khan (Author), Asad U. Khan (Editor) This book contains ten chapters which cover current trends on antibiotic resistance in different parts of the world. Some of the chapters are dedicated to specific type of bacteria like marine and cholera associated microorganisms. Whereas rest of the chapters are mainly focused on the mechanism of drug resistance with special reference to beta lactamases. Since most of the antibiotics used to treat infections belong to -lactam group which is lactam ring (?-lactam) or penam is a lactam with a heteroatomic ring structure, consisting of three carbon atoms and one nitrogen atom. A lactam is a cyclic amide. The main focus of this book is to understand the different molecular markers responsible for developing resistance against this group of antibiotics. CTX-M family... |
| © 2009 BrightSurf.com |